Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study.

Elizabeth T ChinDavid LeidnerYifan ZhangElizabeth LongLea PrinceStephanie J SchragJennifer R VeraniRyan E WiegandFernando Alarid-EscuderoJeremy D Goldhaber-FiebertDavid M StuddertJason R AndrewsJoshua A Salomon

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Consistent with results from randomized trials and observational studies in other populations, mRNA vaccines were highly effective in preventing SARS-CoV-2 infections among incarcerated people. Prioritizing incarcerated people for vaccination, redoubling efforts to boost vaccination, and continuing other ongoing mitigation practices are essential in preventing COVID-19 in this disproportionately affected population.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
randomized controlled trial
primary care
systematic review
healthcare
climate change
quality improvement
genetic diversity